Search Results - "Riester, K"

Refine Results
  1. 1

    Intramuscular interferon beta-1a in chronic inflammatory demyelinating polyradiculoneuropathy by HUGHES, R. A. C, GORSON, K. C, SANDROCK, A, CROS, D, GRIFFIN, J, POLLARD, J, VALLAT, J.-M, MAURER, S. L, RIESTER, K, DAVAR, G, DAWSON, K

    Published in Neurology (23-02-2010)
    “…Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) shares immunologic features with multiple sclerosis (MS). Because IM interferon beta-1a (IM…”
    Get full text
    Journal Article
  2. 2

    CD56(bright) natural killer cells and response to daclizumab HYP in relapsing-remitting MS by Elkins, J, Sheridan, J, Amaravadi, L, Riester, K, Selmaj, K, Bielekova, B, Parr, E, Giovannoni, G

    “…To assess the relationship between CD56(bright) natural killer (NK) cells and multiple sclerosis (MS) disease activity in patients with relapsing-remitting MS…”
    Get full text
    Journal Article
  3. 3

    Sexual, contraceptive, and drug use behaviors of women with HIV and those at high risk for infection : Results from the Women's Interagency HIV Study by WILSON, T. E, MASSAD, L. S, RIESTER, K. A, BARKAN, S, RICHARDSON, J, YOUNG, M, GURTMAN, A, GREENBLATT, R

    Published in AIDS (London) (01-04-1999)
    “…To document the sexual and contraceptive practices of women with HIV infection or who are at risk for infection. Data on the baseline behaviors of 561…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6

    Prevalence and Predictors of Squamous Cell Abnormalities in Papanicolaou Smears From Women Infected With HIV-1 by Massad, L. Stewart, Riester, Katherine A., Anastos, Kathryn M., Fruchter, Rachel G., Palefsky, Joel M., Burk, Robert D., Burns, David, Greenblatt, Ruth M., Muderspach, Laila I., Miotti, Paolo

    “…Cervical cytologic abnormalities were frequent among women infected with HIV, although high-grade changes were found in only 2.5%. Factors linked to sexual and…”
    Get full text
    Journal Article
  7. 7

    Daclizumab HYP versus Interferon Beta-1a in Relapsing Multiple Sclerosis by Kappos, Ludwig, Wiendl, Heinz, Selmaj, Krzysztof, Arnold, Douglas L, Havrdova, Eva, Boyko, Alexey, Kaufman, Michael, Rose, John, Greenberg, Steven, Sweetser, Marianne, Riester, Katherine, O’Neill, Gilmore, Elkins, Jacob

    Published in The New England journal of medicine (08-10-2015)
    “…In this trial, daclizumab high-yield process (a monoclonal antibody that binds to CD25 and modulates interleukin-2 signaling) was more effective than…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Statistical evaluation of the role of Helicobacter pylori in stress gastritis: Applications of splines and bootstrapping to the logistic model by Riester, Katherine A., Peduzzi, Peter, Holford, Theodore R., Ellison, Richard T., Donta, Sam T.

    Published in Journal of clinical epidemiology (01-11-1997)
    “…Stress gastritis is a serious problem in the intensive care unit population. The recent discovery of the causal nature of Helicobacter pylori ( H. pylori) in…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Risk factors for upper gastrointestinal bleeding in intensive care unit patients: Role of Helicobacter pylori by Ellison, Richard T, Perez-Perez, Guillermo, Welsh, Carolyn H, Blaser, Martin J, Riester, Katherine A, Cross, Alan S, Donta, Sam T, Peduzzi, Peter

    Published in Critical care medicine (01-12-1996)
    “…OBJECTIVETo determine the role of preexisting Helicobacter pylori infection in the development of acute upper gastrointestinal (GI) hemorrhage in intensive…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14
  15. 15

    Eight-year immunogenicity and safety of interferon beta-1a-Avonex®treatment in patients with multiple sclerosis by Herndon, Robert M, Rudick, Richard A, Munschauer, Frederick E, Mass, Michele K, Salazar, Andres M, Coats, Michael E, Labutta, Robert, Richert, John R, Cohan, Stanley L, Genain, Claude, Goodkin, Donald, Toal, Martin, Riester, Katherine

    Published in Multiple sclerosis (01-08-2005)
    “…An open-label extension study of the phase III trial of intramuscular interferon beta-1a (IFNβ-1a-Avonex) was conducted to evaluate the immunogenicity and…”
    Get full text
    Journal Article
  16. 16

    Relapse rates and enhancing lesions in a phase II trial of natalizumab in multiple sclerosis by O'Connor, Paul, Miller, David, Riester, Katherine, Yang, Minhua, Panzara, Michael, Dalton, Catherine, Miszkiel, Katherine, Khan, Omar, Rice, George, Sheremata, William

    Published in Multiple sclerosis (01-10-2005)
    “…Background: Natalizumab, a humanized monoclonal IgG4 antibody, is an a4-integrin antagonist, which inhibits the migration of inflammatory cells into the…”
    Get full text
    Journal Article
  17. 17

    Real-time B-scan ultrasonic evaluation of pleural effusion and intrathoracic masses adjacent to the pleura (author's transl) by Schwerk, W B, Riester, K P, Hess, F

    Published in Respiration (1980)
    “…106 pleural effusions or pleural opacities suggesting fluid were evaluated in a prospective study by B-mode real-life sonography and radiography. 41 cases were…”
    Get more information
    Journal Article
  18. 18

    Studies on the leukocytosis and lymphocytosis induced by Bordetella pertussis. I. Radioautographic analysis of the circulating cells in mice undergoing pertussis-induced hyperleukocytosis by Morse, S I, Riester, S K

    Published in The Journal of experimental medicine (01-03-1967)
    “…By the use of radioautographic techniques it was shown that the lymphocytosis induced by Bordetella pertussis in mice was not caused by an increased production…”
    Get full text
    Journal Article
  19. 19

    Studies on the leukocytosis and lymphocytosis induced by Bordetella pertussis. II. The effect of pertussis vaccine on the thoracic duct lymph and lymphocytes of mice by Morse, S I, Riester, S K

    Published in The Journal of experimental medicine (01-04-1967)
    “…The 24 hr volume flow, cell concentration, and total cell output of thoracic duct fluid from mice with pertussis-induced hyperlymphocytosis were markedly…”
    Get full text
    Journal Article
  20. 20

    Eight-year immunogenicity and safety of interferon beta-1a-Avonex registered treatment in patients with multiple sclerosis by Herndon, R M, Rudick, R A, Munschauer, FE III, Mass, M K, Salazar, A M, Coats, ME, Labutta, R, Richert, J R, Cohan, S L, Genain, C, Goodkin, D, Toal, M, Riester, K

    Published in Multiple sclerosis (01-08-2005)
    “…An open-label extension study of the phase III trial of intramuscular interferon beta-1a (IFN beta -1a-Avonex) was conducted to evaluate the immunogenicity and…”
    Get full text
    Journal Article